
On Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose following negotiations with the government but that a final deal had not yet been reached.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31jlotv
via
IFTTT
0 comments:
Post a Comment